Arginase inhibitors as therapeutics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9233985
APP PUB NO 20120129806A1
SERIAL NO

13276806

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds according to Formula I are potent inhibitors of Arginase I and II activity:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MARS INCORPORATED6885 ELM STREET MCLEAN VA 22101-3883

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jagdmann,, Jr Gunnar Erik McLean, US 8 109
Van, Zandt Michael McLean, US 28 263

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00